In the tumor microenvironment, additional factors such as stromal cell interactions, immune cell infiltration, cytokine gradients, and systemic responses (e.g., hormonal or metabolic signals) may influence both p53 activity and TLR3 expression, potentially modulating the outcomes observed here. Here, TP53 is linked to neoplasm.